Ovarian arteries embolization in women with persistent symptoms following uterine arteries embolization for uterus fibroids.
Artery embolization
Leiomyoma
Outcome
Ovaries
Uterine fibroid
Uterus
Journal
Abdominal radiology (New York)
ISSN: 2366-0058
Titre abrégé: Abdom Radiol (NY)
Pays: United States
ID NLM: 101674571
Informations de publication
Date de publication:
12 2021
12 2021
Historique:
received:
30
05
2021
accepted:
16
08
2021
revised:
13
08
2021
pubmed:
26
8
2021
medline:
17
11
2021
entrez:
25
8
2021
Statut:
ppublish
Résumé
In patients with persisting symptoms after uterine arteries embolization (UAE), ovarian arteries embolization (OAE) may play a role to improve symptoms and decrease subsequent surgery rates. In a retrospective cohort, we aimed to investigate the efficacy and safety of OAE in females with recurrent or persistent symptoms following UAE. We performed a retrospective analysis of prospectively collected cases at a single reference academic hospital; we identified patients who benefited from OAE for persisting symptoms following UAE from 2008 to 2021. Outcome variables included the rates of subsequent surgery, a quality-of-life questionnaire with the UFS-QOL tool, the MRI reduction in uterine and fibroids volumes and the fibroid devascularization rate. Among 1300 women treated with UAE during the study period, 18 eventually received OAE and were included (mean age 44 ± 4.3 SD). There was no OAE procedural complication. There was a decrease in uterine volume and a complete devascularization of the dominant fibroid in 10/11 (90.9%) patients who underwent 12 months MRI. Three women underwent subsequent hysterectomy. Among 10/18 patients who answered the quality-of-life questionnaire after a mean follow-up of 70 months, eight reported an improvement or stability of symptoms. OAE for persisting symptoms after UAE was associated with improvement or stability of quality-of-life in most study subjects and less than a fifth of the cohort underwent hysterectomy after OAE. This study highlights the role of OAE as an adjunct to UAE.
Identifiants
pubmed: 34432091
doi: 10.1007/s00261-021-03255-w
pii: 10.1007/s00261-021-03255-w
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
5707-5714Informations de copyright
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Stewart E, Cookson C, Gandolfo R, Schulze-Rath R (2017) Epidemiology of uterine fibroids: a systematic review. BJOG Int J Obstet Gynaecol 124:1501–1512. doi: https://doi.org/10.1111/1471-0528.14640
doi: 10.1111/1471-0528.14640
Ravina, J. H., Herbreteau, D., Ciraru-Vigneron, N., Bouret, J. M., Houdart, E., Aymard, A., & Merland, J. J. (1995). Arterial embolisation to treat uterine myomata. Lancet (London, England), 346(8976), 671–672. doi: https://doi.org/10.1016/s0140-6736(95)92282-2
doi: 10.1016/s0140-6736(95)92282-2
Spies J (2013) Current Evidence on Uterine Embolization for Fibroids. Semin Interv Radiol 30:340–346. doi: https://doi.org/10.1055/s-0033-1359727
doi: 10.1055/s-0033-1359727
Kisilevzky N Kisilevzky Nestor. Uterine embolization for management of symptomatic fibroids: quality-of-life impact. Radiol Bras [Internet]. 2007 Oct [cited 2021 Feb 05] ; 40( 5 ): 289-296. 8
doi: 10.1590/S0100-39842007000500003
Kim HS, Paxton BE, Lee JM (2008) Long-term Efficacy and Safety of Uterine Artery Embolization in Young Patients with and without Uteroovarian Anastomoses. J Vasc Interv Radiol 19:195–200. doi: https://doi.org/10.1016/j.jvir.2007.08.014
doi: 10.1016/j.jvir.2007.08.014
pubmed: 18341948
Manyonda I, Belli A-M, Lumsden M-A, et al (2020) Uterine-Artery Embolization or Myomectomy for Uterine Fibroids. N Engl J Med 383:440–451. doi: https://doi.org/10.1056/NEJMoa1914735
doi: 10.1056/NEJMoa1914735
pubmed: 32726530
Goodwin, S. C., Spies, J. B., Worthington-Kirsch, R., Peterson, E., Pron, G., Li, S., Myers, E. R., & Fibroid Registry for Outcomes Data (FIBROID) Registry Steering Committee and Core Site Investigators (2008). Uterine artery embolization for treatment of leiomyomata: long-term outcomes from the FIBROID Registry. Obstetrics and gynecology, 111(1), 22–33. doi: https://doi.org/10.1097/01.AOG.0000296526.71749.c9
doi: 10.1097/01.AOG.0000296526.71749.c9
pubmed: 18165389
Andrews RT, Bromley PJ, Pfister ME (2000) Successful Embolization of Collaterals from the Ovarian Artery during Uterine Artery Embolization for Fibroids: A Case Report. J Vasc Interv Radiol 11:607–610. doi: https://doi.org/10.1016/S1051-0443(07)61613-3
doi: 10.1016/S1051-0443(07)61613-3
pubmed: 10834492
Matson M, Nicholson A, Belli A-M (2000) Anastomoses of the Ovarian and Uterine Arteries: A Potential Pitfall and Cause of Failure of Uterine Embolization. Cardiovasc Intervent Radiol 23:393–396. doi: https://doi.org/10.1007/s002700010090
doi: 10.1007/s002700010090
pubmed: 11060372
Abbara S, Nikolic B, Pelage J-P, et al (2007) Frequency and Extent of Uterine Perfusion via Ovarian Arteries Observed During Uterine Artery Embolization for Leiomyomas. Am J Roentgenol 188:1558–1563. doi: https://doi.org/10.2214/AJR.05.1383
doi: 10.2214/AJR.05.1383
Pelage JP, Walker WJ, Le Dref O, Rymer R. Ovarian artery: angiographic appearance, embolization and relevance to uterine fibroid embolization. Cardiovasc Intervent Radiol. 2003 May-Jun;26(3):227-33.
doi: 10.1007/s00270-002-1875-3
Razavi MK, Wolanske KA, Hwang GL, Sze DY, Kee ST, Dake MD. Angiographic classification of ovarian artery-to-uterine artery anastomoses: initial observations in uterine fibroid embolization. Radiology. 2002; 224:707–712.
doi: 10.1148/radiol.2243011513
Barth MM, Spies JB. Ovarian artery embolization supplementing uterine embolization for leiomyomata. J Vasc Interv Radiol. 2003 Sep;14(9 Pt 1):1177-82.
doi: 10.1097/01.RVI.0000085772.71254.CF
Hu NN, Kaw D, McCullough MF, Nsouli-Maktabi H, Spies JB. Menopause and menopausal symptoms after ovarian artery embolization: a comparison with uterine artery embolization controls. J Vasc Interv Radiol. 2011 May;22(5):710-715.e1.
doi: 10.1016/j.jvir.2011.01.441
Campbell J, Rajan DK, Kachura JR, et al. Efficacy of ovarian artery embolization for uterine fibroids: clinical and magnetic resonance imaging evaluations. Can Assoc Radiol J. 2015 May;66(2):164-70.
doi: 10.1016/j.carj.2014.08.005
Von Elm E, Altman DG, Egger M, et al (2007) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 370:1453–1457. doi: https://doi.org/10.1016/S0140-6736(07)61602-X
doi: 10.1016/S0140-6736(07)61602-X
Spies JB, Coyne K, Guaou Guaou N, Boyle D, Skyrnarz-Murphy K, Gonzalves SM. The UFS-QOL, a new disease-specific symptom and health-related quality of life questionnaire for leiomyomata. Obstet Gynecol. 2002 Feb;99(2):290-300.
pubmed: 11814511
Salazar GMM, Gregory Walker T, Conway RF, et al (2013) Embolization of Angiographically Visible Type I and II Utero-ovarian Anastomoses during Uterine Artery Embolization for Fibroid Tumors: Impact on Symptom Recurrence and Permanent Amenorrhea. J Vasc Interv Radiol 24:1347–1352. doi: https://doi.org/10.1016/j.jvir.2013.05.043
doi: 10.1016/j.jvir.2013.05.043
pubmed: 23871695
Pelage JP, Le Dref O, Soyer P, et al (1999) Arterial anatomy of the female genital tract: variations and relevance to transcatheter embolization of the uterus. Am J Roentgenol 172:989–994. doi: https://doi.org/10.2214/ajr.172.4.10587133
doi: 10.2214/ajr.172.4.10587133
Kozik W, Czerwiński F, Pilarczyk K, Partyka C. Arteries of the hilum and parenchymal part of the ovary in reproductive age in microangiographic studies. Ginekol Pol. 2002 Dec;73(12):1173-8.
pubmed: 12722464
Riu P, Vallone C, Rigon G, Signore F (2013) Anomalous ovarian artery vascularisation of a large uterine fibroid: successful embolisation. Case Rep 2013:bcr2012008106–bcr2012008106. doi: https://doi.org/10.1136/bcr-2012-008106
doi: 10.1136/bcr-2012-008106
Nikolic, B., Spies, J. B., Abbara, S., & Goodwin, S. C. (1999). Ovarian artery supply of uterine fibroids as a cause of treatment failure after uterine artery embolization: a case report. Journal of vascular and interventional radiology : JVIR, 10(9), 1167–1170. doi: https://doi.org/10.1016/s1051-0443(99)70215-0
doi: 10.1016/s1051-0443(99)70215-0
pubmed: 10527192
Pelage J-P, Cazejust J, Pluot E, et al (2005) Uterine Fibroid Vascularization and Clinical Relevance to Uterine Fibroid Embolization. RadioGraphics 25:S99–S117. doi: https://doi.org/10.1148/rg.25si055510
doi: 10.1148/rg.25si055510
pubmed: 16227501
Kim HS, Tsai J, Patra A, et al (2006) Effects of Utero-ovarian Anastomoses on Clinical Outcomes and Repeat Intervention Rates after Uterine Artery Embolization. J Vasc Interv Radiol 17:783–789. doi: https://doi.org/10.1097/01.RVI.0000209342.02567.C2
doi: 10.1097/01.RVI.0000209342.02567.C2
pubmed: 16687743
The French Society of Interventional and cardiovascular Imaging (SFICV) research group, Kovacsik HV, Herbreteau D, et al (2017) Evaluation of Changes in Sexual Function Related to Uterine Fibroid Embolization (UFE): Results of the EFUZEN Study. Cardiovasc Intervent Radiol 40:1169–1175. doi: https://doi.org/10.1007/s00270-017-1615-3
doi: 10.1007/s00270-017-1615-3